Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis
2020-01-01 Sands, Be; Taub, Pr; Armuzzi, A; Friedman, Gs; Moscariello, M; Lawendy, N; Pedersen, Rd; Chan, G; Nduaka, Ci; Quirk, D; Salese, L; Su, C; Feagan, Bg
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
2019-01-01 Guidi, L; Pugliese, D; Panici Tonucci, T; Bertani, L; Costa, F; Privitera, G; Tolusso, B; Di Mario, C; Albano, E; Tapete, G; Gremese, E; Papa, A; Gasbarrini, A; Rapaccini, Gl; Armuzzi, A
Female reproductive health and inflammatory bowel disease: A practice-based review
2022-01-01 Armuzzi, A; Bortoli, A; Castiglione, F; Contaldo, A; Daperno, M; D'Incà, R; Labarile, N; Mazzuoli, S; Onali, S; Milla, M; Orlando, A; Principi, M; Pugliese, D; Renna, S; Rizzello, F; Scribano, Ml; Todeschini, A; Italian Group for the Study of Inflammatory Bowel Disease Working, Group.
Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases
2014-01-01 Felice, C; Lewis, A; Armuzzi, Alessandro; Lindsay, Jo; Silver, A.
NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population
2003-01-01 Leong, Rwl; Armuzzi, A; Ahmad, T; Wong, Ml; Tse, P; Jewell, Dp; Sung, Jjy
No evidence of Helicobacter pylori sequences in pancreatic juices of patients affected by chronic pancreatitis
2000-01-01 Di Campli, C; Nocente, R; Costamagna, G; Gentiloni, N; Burioni, R; Wu, J; Armuzzi, A; Zern, Ma; Gasbarrini, G; Gasbarrini, A
Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease
2021-01-01 Sousa, P; Ministro, P; Armuzzi, A; Dignass, A; Høivik, Ml; Barreiro-de Acosta, M; Vavricka, S; Saad-Hossne, R; Kotze, Pg; Peyrin-Biroulet, L; Magro, F
Growth hormone in inflammatory bowel disease
2006-01-01 De Pascalis, B; Bianchi, A; Satta, Ma; Lupascu, A; Mentella, Mc; Leo, D; Fiore, F; Fedeli, P; Pontecorvi, A; Pola, P; Melina, D; Gasbarrini, A; De Marinis, L; Armuzzi, A
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases
2014-01-01 Blandizzi, C; Gionchetti, P; Armuzzi, Alessandro; Caporali, R; Chimenti, S; Cimaz, R; Cimino, L; Lapadula, G; Lionetti, P; Marchesoni, A; Marcellusi, A; Mennini, Fs; Salvarani, C; Girolomoni, G.
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease
2015-01-01 Monteleone, G; Neurath, Mf; Ardizzone, S; Di Sabatino, A; Fantini, Mc; Castiglione, F; Scribano, Ml; Armuzzi, A; Caprioli, F; Sturniolo, Gc; Rogai, F; Vecchi, M; Atreya, R; Bossa, F; Onali, S; Fichera, M; Corazza, Gr; Biancone, L; Savarino, V; Pica, R; Orlando, A; Pallone, F
13C-breath tests in the study of mitochondrial liver function
2004-01-01 Candelli, M; Cazzato, Ia; Zocco, Ma; Nista, Ec; Fini, L; Armuzzi, A; Camise, V; Santoro, M; Miele, L; Grieco, A; Gasbarrini, G; Gasbarrini, A
Diet and Nutrients in Gastrointestinal Chronic Diseases
2020-01-01 Corsello, A; Pugliese, D; Gasbarrini, A; Armuzzi, A
Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease
2003-01-01 Gasbarrini, A; Ojetti, V; Cuoco, L; Cammarota, G; Migneco, A; Armuzzi, A; Pola, P; Gasbarrini, G
Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach
2021-01-01 Corsello, A; Pugliese, D; Bracci, F; Knafelz, D; Papadatou, B; Aloi, M; Cucchiara, S; Guidi, L; Gasbarrini, A; Armuzzi, A
Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study
2018-01-01 Pugliese, D; Aratari, A; Festa, S; Ferraro, Pm; Monterubbianesi, R; Guidi, L; Scribano, Ml; Papi, C; Armuzzi, A
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis
2007-01-01 Montalto, M; Curigliano, V; Santoro, L; Armuzzi, A; Cammarota, G; Covino, M; Mentella, Mc; Ancarani, F; Manna, R; Gasbarrini, A; Gasbarrini, G
Assessment of neurological manifestations in hospitalized patients with COVID-19
2020-01-01 Luigetti, M; Iorio, R; Bentivoglio, Ar; Tricoli, L; Riso, V; Marotta, J; Piano, C; Primiano, G; Zileri Del Verme, L; Lo Monaco, Mr; Calabresi, P; GEMELLI AGAINST COVID-19, Group; Armuzzi, A
Levofloxacin based regimens for the eradication of Helicobacter pylori
2002-01-01 Di Caro, S; Zocco, Ma; Cremonini, F; Candelli, M; Nista, Ec; Bartolozzi, F; Armuzzi, A; Cammarota, G; Santarelli, L; Gasbarrini, A
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study
2021-01-01 Pugliese, D; Privitera, G; Rogai, F; Variola, A; Viola, A; Laterza, L; Privitera, Ac; Allocca, M; Bossa, F; Cappello, M; Daperno, M; Lorenzon, G; Mazzuoli, S; Principi, M; Sablich, R; Moser, L; Ferronato, A; Traini, S; Tapete, G; Bodini, G; Di Girolamo, M; Grossi, L; Mocci, G; Ricci, C; Saibeni, S; Festa, S; Spagnuolo, R; Cortelezzi, Cc; Mocciaro, F; Rizzello, F; Armuzzi, A; Italian Group for the Study of Inflammatory Bowel Disease, (IG-IBD)
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection
1999-01-01 Cammarota, G; Cannizzaro, O; Cianci, R; Armuzzi, A; Gasbarrini, A; Pastorelli, A; Papa, A; Gasbarrini, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis | 1-gen-2020 | Sands, Be; Taub, Pr; Armuzzi, A; Friedman, Gs; Moscariello, M; Lawendy, N; Pedersen, Rd; Chan, G; Nduaka, Ci; Quirk, D; Salese, L; Su, C; Feagan, Bg | |
| Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease | 1-gen-2019 | Guidi, L; Pugliese, D; Panici Tonucci, T; Bertani, L; Costa, F; Privitera, G; Tolusso, B; Di Mario, C; Albano, E; Tapete, G; Gremese, E; Papa, A; Gasbarrini, A; Rapaccini, Gl; Armuzzi, A | |
| Female reproductive health and inflammatory bowel disease: A practice-based review | 1-gen-2022 | Armuzzi, A; Bortoli, A; Castiglione, F; Contaldo, A; Daperno, M; D'Incà, R; Labarile, N; Mazzuoli, S; Onali, S; Milla, M; Orlando, A; Principi, M; Pugliese, D; Renna, S; Rizzello, F; Scribano, Ml; Todeschini, A; Italian Group for the Study of Inflammatory Bowel Disease Working, Group. | |
| Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases | 1-gen-2014 | Felice, C; Lewis, A; Armuzzi, Alessandro; Lindsay, Jo; Silver, A. | |
| NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population | 1-gen-2003 | Leong, Rwl; Armuzzi, A; Ahmad, T; Wong, Ml; Tse, P; Jewell, Dp; Sung, Jjy | |
| No evidence of Helicobacter pylori sequences in pancreatic juices of patients affected by chronic pancreatitis | 1-gen-2000 | Di Campli, C; Nocente, R; Costamagna, G; Gentiloni, N; Burioni, R; Wu, J; Armuzzi, A; Zern, Ma; Gasbarrini, G; Gasbarrini, A | |
| Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease | 1-gen-2021 | Sousa, P; Ministro, P; Armuzzi, A; Dignass, A; Høivik, Ml; Barreiro-de Acosta, M; Vavricka, S; Saad-Hossne, R; Kotze, Pg; Peyrin-Biroulet, L; Magro, F | |
| Growth hormone in inflammatory bowel disease | 1-gen-2006 | De Pascalis, B; Bianchi, A; Satta, Ma; Lupascu, A; Mentella, Mc; Leo, D; Fiore, F; Fedeli, P; Pontecorvi, A; Pola, P; Melina, D; Gasbarrini, A; De Marinis, L; Armuzzi, A | |
| The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases | 1-gen-2014 | Blandizzi, C; Gionchetti, P; Armuzzi, Alessandro; Caporali, R; Chimenti, S; Cimaz, R; Cimino, L; Lapadula, G; Lionetti, P; Marchesoni, A; Marcellusi, A; Mennini, Fs; Salvarani, C; Girolomoni, G. | |
| Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease | 1-gen-2015 | Monteleone, G; Neurath, Mf; Ardizzone, S; Di Sabatino, A; Fantini, Mc; Castiglione, F; Scribano, Ml; Armuzzi, A; Caprioli, F; Sturniolo, Gc; Rogai, F; Vecchi, M; Atreya, R; Bossa, F; Onali, S; Fichera, M; Corazza, Gr; Biancone, L; Savarino, V; Pica, R; Orlando, A; Pallone, F | |
| 13C-breath tests in the study of mitochondrial liver function | 1-gen-2004 | Candelli, M; Cazzato, Ia; Zocco, Ma; Nista, Ec; Fini, L; Armuzzi, A; Camise, V; Santoro, M; Miele, L; Grieco, A; Gasbarrini, G; Gasbarrini, A | |
| Diet and Nutrients in Gastrointestinal Chronic Diseases | 1-gen-2020 | Corsello, A; Pugliese, D; Gasbarrini, A; Armuzzi, A | |
| Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease | 1-gen-2003 | Gasbarrini, A; Ojetti, V; Cuoco, L; Cammarota, G; Migneco, A; Armuzzi, A; Pola, P; Gasbarrini, G | |
| Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach | 1-gen-2021 | Corsello, A; Pugliese, D; Bracci, F; Knafelz, D; Papadatou, B; Aloi, M; Cucchiara, S; Guidi, L; Gasbarrini, A; Armuzzi, A | |
| Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study | 1-gen-2018 | Pugliese, D; Aratari, A; Festa, S; Ferraro, Pm; Monterubbianesi, R; Guidi, L; Scribano, Ml; Papi, C; Armuzzi, A | |
| Fecal calprotectin in first-degree relatives of patients with ulcerative colitis | 1-gen-2007 | Montalto, M; Curigliano, V; Santoro, L; Armuzzi, A; Cammarota, G; Covino, M; Mentella, Mc; Ancarani, F; Manna, R; Gasbarrini, A; Gasbarrini, G | |
| Assessment of neurological manifestations in hospitalized patients with COVID-19 | 1-gen-2020 | Luigetti, M; Iorio, R; Bentivoglio, Ar; Tricoli, L; Riso, V; Marotta, J; Piano, C; Primiano, G; Zileri Del Verme, L; Lo Monaco, Mr; Calabresi, P; GEMELLI AGAINST COVID-19, Group; Armuzzi, A | |
| Levofloxacin based regimens for the eradication of Helicobacter pylori | 1-gen-2002 | Di Caro, S; Zocco, Ma; Cremonini, F; Candelli, M; Nista, Ec; Bartolozzi, F; Armuzzi, A; Cammarota, G; Santarelli, L; Gasbarrini, A | |
| Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study | 1-gen-2021 | Pugliese, D; Privitera, G; Rogai, F; Variola, A; Viola, A; Laterza, L; Privitera, Ac; Allocca, M; Bossa, F; Cappello, M; Daperno, M; Lorenzon, G; Mazzuoli, S; Principi, M; Sablich, R; Moser, L; Ferronato, A; Traini, S; Tapete, G; Bodini, G; Di Girolamo, M; Grossi, L; Mocci, G; Ricci, C; Saibeni, S; Festa, S; Spagnuolo, R; Cortelezzi, Cc; Mocciaro, F; Rizzello, F; Armuzzi, A; Italian Group for the Study of Inflammatory Bowel Disease, (IG-IBD) | |
| Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection | 1-gen-1999 | Cammarota, G; Cannizzaro, O; Cianci, R; Armuzzi, A; Gasbarrini, A; Pastorelli, A; Papa, A; Gasbarrini, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891